Literature DB >> 2153243

Proviral insertions within the int-2 gene can generate multiple anomalous transcripts but leave the protein-coding domain intact.

C Dickson1, R Smith, S Brookes, G Peters.   

Abstract

We examined the effects of mouse mammary tumor virus integration on the multiple RNA transcripts expressed from the int-2 proto-oncogene in virally induced breast tumors. Proviral insertion either upstream or downstream of the gene could simultaneously activate transcription from three dissimilar int-2 promoters. In some tumors, the activating provirus lies within the transcription unit and disrupts the structures of the various RNAs. Insertions in the 5' region of the gene had complex effects depending on the orientation and position of the provirus relative to the three promoters and intron-exon boundaries. RNase protection experiments identified transcripts initiated in the viral long terminal repeat, at normal and cryptic sites in the int-2 sequences, and from cryptic promoters in an inverted provirus. AT the 3' end, insertions occurred within the untranslated trailer and provided alternative termination signals that substituted for one or both of the normal the poly(A) addition sites. However, in no instance, of the 20 tumors analyzed in detail, did a provirus perturb the presumed open reading frame of the gene. These data strongly implicate the normal product of the int-2 gene, which is related to the fibroblast growth factor family, as a contributory factor in virally induced mammary tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153243      PMCID: PMC249173     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.

Authors:  M Emerman; H M Temin
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

2.  Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis.

Authors:  B R Cullen; P T Lomedico; G Ju
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

3.  Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2.

Authors:  C Dickson; R Smith; S Brookes; G Peters
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

4.  Nucleotide sequence 5' of the chicken c-myc coding region: localization of a noncoding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas.

Authors:  C K Shih; M Linial; M M Goodenow; W S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact.

Authors:  A van Ooyen; R Nusse
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

6.  Transcription of three c-myc exons is enhanced in chicken bursal lymphoma cell lines.

Authors:  M Linial; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.

Authors:  R Nusse; A van Ooyen; D Cox; Y K Fung; H Varmus
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

8.  Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors.

Authors:  G Peters; S Brookes; R Smith; C Dickson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

9.  Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.

Authors:  G Selten; H T Cuypers; A Berns
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

10.  Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation.

Authors:  G Selten; H T Cuypers; M Zijlstra; C Melief; A Berns
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  7 in total

1.  Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia.

Authors:  Keshet Ronen; Olivier Negre; Shannah Roth; Charlotte Colomb; Nirav Malani; Maria Denaro; Troy Brady; Floriane Fusil; Beatrix Gillet-Legrand; Kathleen Hehir; Yves Beuzard; Philippe Leboulch; Julian D Down; Emmanuel Payen; Frederic D Bushman
Journal:  Mol Ther       Date:  2011-03-08       Impact factor: 11.454

2.  Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines.

Authors:  P Lefebvre; D S Berard; M G Cordingley; G L Hager
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

3.  CDP is a repressor of mouse mammary tumor virus expression in the mammary gland.

Authors:  Q Zhu; K Gregg; M Lozano; J Liu; J P Dudley
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.

Authors:  H Kwan; V Pecenka; A Tsukamoto; T G Parslow; R Guzman; T P Lin; W J Muller; F S Lee; P Leder; H E Varmus
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

5.  Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.

Authors:  Magdalena Julia Dabrowska; Karen Dybkaer; Hans Erik Johnsen; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

6.  Mouse mammary tumor virus sequences responsible for activating cellular oncogenes.

Authors:  S L Grimm; S K Nordeen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

7.  Activation of the mouse mdr3 gene by insertion of retroviruses in multidrug-resistant P388 tumor cells.

Authors:  P Lepage; A Devault; P Gros
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.